Search
Purple Biotech Ltd
PPBTAdd to Watchlist
1.680USD
-0.060-3.45%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
1.52MMarket Cap
LossP/E TTM
More Details of Purple Biotech Ltd Company
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd Info
Ticker SymbolPPBT
Company namePurple Biotech Ltd
IPO dateSep 03, 1978
CEOEfron (Gil)
Number of employees9
Security typeDepository Receipt
Fiscal year-endSep 03
Address4 Oppenheimer St.
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670104
Phone97239333121
Websitehttps://purple-biotech.com/
Ticker SymbolPPBT
IPO dateSep 03, 1978
CEOEfron (Gil)
Company Executives of Purple Biotech Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Mr. Ran Tzror
Mr. Ran Tzror
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
FAQs
Who are the top five shareholders of Purple Biotech Ltd?
The top five shareholders of Purple Biotech Ltd are: Mr. Itzhak Israel
How many institutions hold shares of Purple Biotech Ltd (PPBT)?
As of 2026Q1, 40 institutions hold shares of Purple Biotech Ltd, with a combined market value of approximately 121.71K, accounting for 13.10% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 86679.00.
